Nanoparticles in Ocular Drug Delivery Systems.

Area of Science:

• Ophthalmology
• Pharmaceutics
• Drug Delivery Systems

Background:

• Conventional ophthalmic formulations exhibit limited precorneal residence time.
• Lack of mucoadhesive properties in traditional eye drops reduces ocular drug penetration.
• This leads to suboptimal bioavailability and diminished therapeutic outcomes.

Discussion:

• Investigating novel ophthalmic formulations to overcome limitations of conventional eye drops.
• Focus on achieving prolonged drug release and enhanced mucoadhesive properties.
• Improving ocular drug penetration and bioavailability for better therapeutic efficacy.

Key Insights:

• Developed advanced ophthalmic formulations with prolonged drug release.
• Achieved significant mucoadhesive properties for extended ocular residence.
• Demonstrated enhanced drug penetration and bioavailability in ocular tissues.

Outlook:

• Potential for improved treatment of ocular diseases with novel formulations.
• Further research into long-term efficacy and safety of these advanced drug delivery systems.
• Paving the way for next-generation ophthalmic therapeutics.